Abstract
ObjectiveWe evaluated the efficacy and safety of ledipasvir/sofosbuvir alone and with ribavirin for 8 and 12 weeks in Egyptian patients with and without cirrhosis, who were infected with hepatitis C...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have